Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc.

Advanced Plant Pharmaceuticals Appoints Dr. Mechael Kanovsky as President of its Subsidiary Pharmaceutical Company Mazal Plant Pharmaceuticals Inc. Company announces the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc.; Mazel to focus on Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Herbalife Names Three Additional Members to Board of Directors Leroy T. Barnes, Jr., Richard Bermingham and Peter Maslen will join the nine current members of the Board. Planet Organic to Acquire 17 Store Chain Company has signed a letter of intent to acquire Newfound Health, a profitable company with 17 franchise locations throughout Alberta. Planet Organic to Acquire 17 Store Chain Company has signed a letter of intent to acquire Newfound Health, a profitable company with 17 franchise locations throughout Alberta. Wild Oats Markets, Inc. Reports Preliminary Fourth Quarter and Year-End 2004 Results Company to restate prior period financial statements; will not have an impact on the Company's cash position, net sales or same-store sales. Preliminary 04 results show net sales of $1.05 billion, an 8.1 percent increase over net sales of $969.2 million in 2003. Comparable store sales in 2004 increased 1.4 percent. Wild Oats Markets, Inc. Reports Preliminary Fourth Quarter and Year-End 2004 Results Company to restate prior period financial statements; will not have an impact on the Company's cash position, net sales or same-store sales. Preliminary 04 results show net sales of $1.05 billion, an 8.1 percent increase over net sales of $969.2 million in 2003. Comparable store sales in 2004 increased 1.4 percent. NeuroNutrition, Inc., Forms Strategic Alliance With ProfileHealth In this agreement, NeuroNutrition will feature the HormoneProfile test kit produced by ProfileHealth and ProfileHealth will promote NeuroNutrition's line of products. NeuroNutrition, Inc., Forms Strategic Alliance With ProfileHealth In this agreement, NeuroNutrition will feature the HormoneProfile test kit produced by ProfileHealth and ProfileHealth will promote NeuroNutrition's line of products. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Bio-One Removes CEO, Appoints Interim CEO Board has appointed Frank M. Clark as interim CEO, David G. Collins, C.P.A., Chairman of the Audit Committee, will serve as interim CFO. Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Levlad/Nature's Gate(R) Names Paddy Spence as President Spence will be responsible for the company's branded and private label businesses and will serve as a member of the board of directors for Natural Products Group, LLC, the holding company for Levlad and Arbonne International. Herbalife Ltd. Announces 2004 Net Sales Company announces sales increase of 13% to $1.3 billion while net income rose to $46.2 million compared to $36.8 million in 2003. Including pre-tax recapitalization expenses of $71.5 million, the company reported a net loss of $14.3 million, or 27 cents per share. Herbalife Ltd. Announces 2004 Net Sales Company announces sales increase of 13% to $1.3 billion while net income rose to $46.2 million compared to $36.8 million in 2003. Including pre-tax recapitalization expenses of $71.5 million, the company reported a net loss of $14.3 million, or 27 cents per share. Vital Living Acquires 100% Interest in Wellness Watchers Systems, LLC Company acquires 100% interest in Wellness Watchers Systems, LLC (WWS), formerly a 50/50 joint venture between Vital Living and Wellness Watchers International Inc. with product and service offerings to be integrated into Vital Living's wholly owned subsidiary, Doctors For Nutrition Inc. Vital Living Acquires 100% Interest in Wellness Watchers Systems, LLC Company acquires 100% interest in Wellness Watchers Systems, LLC (WWS), formerly a 50/50 joint venture between Vital Living and Wellness Watchers International Inc. with product and service offerings to be integrated into Vital Living's wholly owned subsidiary, Doctors For Nutrition Inc. Biogaia Signs Agreement In Hong Kong Company signs 5-year agreement with J Health Enterprise Ltd for exclusive rights to distribute Reuteri tablets in Hong Kong. Biogaia Signs Agreement In Hong Kong Company signs 5-year agreement with J Health Enterprise Ltd for exclusive rights to distribute Reuteri tablets in Hong Kong. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Zila Strengthens Management Team Company announces appointment of Gary V. Klinefelter as Vice President and General Counsel. Nestlé Full-Year Results Announced Company reports net profit up 8.1% to CHF 6.7 billion ($5.77 billion), as net debt reduced to CHF 10.2 billion from CHF 14.4 billion in 2003; consolidated sales reach CHF 86 769 million ($74.78 billion), EBITA reaches CHF 10 970 million. Nestlé Full-Year Results Announced Company reports net profit up 8.1% to CHF 6.7 billion ($5.77 billion), as net debt reduced to CHF 10.2 billion from CHF 14.4 billion in 2003; consolidated sales reach CHF 86 769 million ($74.78 billion), EBITA reaches CHF 10 970 million. Health Sciences Group Acquires Open Cell Biotechnologies, Inc. From UTEK Corporation Company acquires Open Cell Biotechnologies, Inc., a wholly-owned subsidiary of UTEK Corporation, in a stock transaction; OCBI holds the exclusive license from Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to a patented process for the production of open-cell sponge food. Health Sciences Group Acquires Open Cell Biotechnologies, Inc. From UTEK Corporation Company acquires Open Cell Biotechnologies, Inc., a wholly-owned subsidiary of UTEK Corporation, in a stock transaction; OCBI holds the exclusive license from Yissum, the Technology Transfer Company of the Hebrew University of Jerusalem, to a patented process for the production of open-cell sponge food. United Natural Foods Announces Second Quarter Results Company reports net income of $9.4 million for the second quarter on sales for the second quarter of $504.7 million. United Natural Foods Announces Second Quarter Results Company reports net income of $9.4 million for the second quarter on sales for the second quarter of $504.7 million. Fonterra Lifts Bid for National Foods Company announces that it will top San Miguel Corporation’s offer for National Foods by 10 cents per share, increasing to 30 cents per share if it acquires 90% or more of National Foods; revised offer is at $6.00 per share, $6.20 if over 90%. Fonterra Lifts Bid for National Foods Company announces that it will top San Miguel Corporation’s offer for National Foods by 10 cents per share, increasing to 30 cents per share if it acquires 90% or more of National Foods; revised offer is at $6.00 per share, $6.20 if over 90%. Reliv International Reports 2004 Results Company reports 24% increase in net income, from $4.34 million or $0.26 per share diluted to $5.37 million or $0.31 per share diluted, on sales of $96.98 million compared to $76.96 million in 2003. Reliv International Reports 2004 Results Company reports 24% increase in net income, from $4.34 million or $0.26 per share diluted to $5.37 million or $0.31 per share diluted, on sales of $96.98 million compared to $76.96 million in 2003. Burcon Announces Third Quarter Results Company reports net loss of $637,306 ($0.04 per share) for FY05 Q3, compared to $579,818 ($0.04 per share) for same period in FY03. Burcon Announces Third Quarter Results Company reports net loss of $637,306 ($0.04 per share) for FY05 Q3, compared to $579,818 ($0.04 per share) for same period in FY03. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. NutraCea(R) Names Mr. David Bensol To Board Of Directors Mr. David Bensol, the former CEO of Critical Home Care has been appointed to NutraCea's Board of Directors. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Health Enhancement Products Appoints Thomas Ingolia to Head up Advisory Board; Steven Rittmanic Also Appointed to Advisory Board Company appoints Thomas D. Ingolia, President and CEO of Prolexys Pharmaceutical, Inc., to chair and recruit the members of a new advisory board. Dynamic Health to Acquire Sports Nutrition and Performance Drink Distributor Company has entered into an agreement and plan of merger to acquire Dynamic Marketing, Inc. and will pay consideration in excess of $3 million, consisting of cash and stock. Dynamic Health to Acquire Sports Nutrition and Performance Drink Distributor Company has entered into an agreement and plan of merger to acquire Dynamic Marketing, Inc. and will pay consideration in excess of $3 million, consisting of cash and stock. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. PharmaNutrients Launches New CLA Technology: Dual Mechanism CLA One(R) DG Company introduces new patented, dual mechanism technology that delivers CLA One as a diglyceride, suitable for use in dietary supplements and food products. Chr. Hansen Celebrates Official Opening of New Office in Dubai Company opened Middle East and Africa headquarters on February 24, 2005. Chr. Hansen Celebrates Official Opening of New Office in Dubai Company opened Middle East and Africa headquarters on February 24, 2005. Vital Living Enters into Agreement with Wellness Now, LLC Company announces agreement with Wellness Now, LLC, to act as a Master Distributor for all areas of the United States that are not presently being reached by the company's current distribution channels. Vital Living Enters into Agreement with Wellness Now, LLC Company announces agreement with Wellness Now, LLC, to act as a Master Distributor for all areas of the United States that are not presently being reached by the company's current distribution channels. Leading Yerba Maté Brand Gets Boost by Partnering with Oasis Sales and Marketing Company announces a strategic partnership with Oasis Sales & Marketing to expand sales programs. Leading Yerba Maté Brand Gets Boost by Partnering with Oasis Sales and Marketing Company announces a strategic partnership with Oasis Sales & Marketing to expand sales programs. Spectrum Organic Products Reports Sales for 2004 Company reports net sales for FY04 of $49,915,400 versus $45,676,500 prior year, with the Spectrum Naturals(R) brand of culinary products up 17% and the Spectrum Ingredients Division industrial culinary sales increasing by 11%. Company's Spectrum Essentials(R) brand of nutritional supplements had sales fall by 8%. Company reports net loss of $832,700 or $0.02 per share versus net income of $2,663,600 ($0.06 per share) for the prior year. Spectrum Organic Products Reports Sales for 2004 Company reports net sales for FY04 of $49,915,400 versus $45,676,500 prior year, with the Spectrum Naturals(R) brand of culinary products up 17% and the Spectrum Ingredients Division industrial culinary sales increasing by 11%. Company's Spectrum Essentials(R) brand of nutritional supplements had sales fall by 8%. Company reports net loss of $832,700 or $0.02 per share versus net income of $2,663,600 ($0.06 per share) for the prior year. BioGaia Signs Agreement In India Company sings agreement with India's Uni-Sankyo that gives Uni-Sankyo the right to produce and sell dietary supplements with Reuteri in India. BioGaia Signs Agreement In India Company sings agreement with India's Uni-Sankyo that gives Uni-Sankyo the right to produce and sell dietary supplements with Reuteri in India. Ariel Calmanovici Named CFO of Frutarom USA Inc. Company appoints Ariel Calmanovici as Chief Financial Officer of Frutarom USA INc. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	NEW YORK, Mar 1, 2005 (PRIMEZONE via COMTEX) -- David Lieberman, CEO of Advanced Plant Pharmaceuticals, Inc., (APPI) announced today the appointment of Dr. Mechael Kanovsky as President of Mazal Plant Pharmaceuticals Inc. to assist in the development of its three intended pharmaceutical formulas targeted for the treatment of high cholesterol, leukemia and Alzheimer's disease. Dr. Mechael Kanovsky earned his PhD in Molecular Biology at Mount Sinai Medical School in New York and conducted cancer research initially in academia at the State University of New York (SUNY Downstate). Dr. Kanovsky moved into the biotech industry continuing his research on cancer and gene therapy at Gene Vector Technologies (Israel) and Marantech, Inc. (USA). Dr Kanovsky, President of Mazal Plant Pharmaceuticals, stated that he was pleased to be joining Mazal Plant Pharmaceuticals. My initial goal is to focus on the Clinical IND/ NDA development of Mazal's cholesterol drug formula into a targeted cholesterol /HDL and triglyceride drug. As previously announced, APPI owns 7,000,000 shares of common stock of Mazal and, as a result, is the majority shareholder. In addition, APPI will receive a royalty from Mazal on the three pharmaceutical formulas sold by APPI to Mazal Plant Pharmaceuticals. Mazal's initial plans are to apply for an Investigational New Drug from the FDA and to pursue Phase II clinical trials for its cholesterol drug, MAHDL. APPI continues to pursue sales of its nutritional product, Lo-Chol, targeted for the nutritional cholesterol market and Sinusol, an OTC homeopathic drug, for the treatment of sinus and allergy ailments. About Advanced Plant Pharmaceuticals, Inc. Advanced Plant Pharmaceuticals, Inc. (APPI) focuses on the research and development of whole plant-based products. The company has a composition-oriented patent for a proprietary process of utilizing whole plants to safely manufacture all-natural nutritional supplements. For more information, visit the Company's Corporate website: http://www.advancedplantpharm.com About Mazal Pharmaceuticals, Inc. Mazal Pharmaceuticals is focused on becoming an Industry leader in the treatment of Cholesterol /HDL and Triglyceride Treatment. Mazal Plant Pharmaceuticals is an innovator of whole plant pharmaceuticals drugs focused on the utilization of whole plants in the development of healthier pharmaceutical drugs for the treatment of human diseases. Corporate website: www.mazal.cc Forward-Looking Statements This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software